Search | Page 37 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 10:36am.

  2. SCT Plus Immune Therapy in Average Risk AML/MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 9:52am.

  3. Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of AG-881 in advanced hematologic malignancies that harbor an ...

    Clinical Trial last updated 04/28/2016 - 10:59am.

  4. Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome (SS1)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... This pilot study investigates clinical benefit of four 28-day cycles of sertraline in low-risk MDS patients. ...

    Clinical Trial last updated 04/28/2016 - 10:17am.

  5. T-cell Depleted Alternative Donor Transplantation

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... ejection fraction < 45%; can be lower if patient is not in clinical cardiac failure and a reduced intensity conditioning regimen is used. ...

    Clinical Trial last updated 04/29/2016 - 3:38pm.

  6. Study of INCB053914 in Subjects With Advanced Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/02/2016 - 4:09pm.

  7. Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/02/2016 - 2:38pm.

  8. Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... This is a Phase 2, open-label, randomized, controlled clinical study of pediatric subjects treated with pamidronate with calcium and ...

    Clinical Trial last updated 04/27/2016 - 3:48pm.

  9. Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... to assess the safety, tolerability, and preliminary clinical effects of BVD-523 given orally, twice daily for 21-day cycles, in ...

    Clinical Trial last updated 04/27/2016 - 3:39pm.

  10. Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral CDAi in Patients With MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... stage the selected dose will be confirmed and evaluated for clinical activity, including response rate. ...

    Clinical Trial last updated 04/27/2016 - 2:05pm.